Skip to main content
Year archive

Kamada Ltd. — 2025 filings

All 54 regulatory filings released by Kamada Ltd. (KMDA) in 2025, sourced directly from the official regulator.

54 Filings
2025 Period
2025 filings (54)
Filing Released Lang
6k-Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
Regulatory Filings
2025-12-18 English
6k-Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
Report Publication Announcement
2025-12-18 English
Annual General Meeting of Shareholders-results
Remuneration Information
2025-12-10 English
Annual General Meeting of Shareholders-results
Report Publication Announcement
2025-12-10 English
Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects DoubleDigit Growth in Rrvenues and profitability in 2026
Regulatory Filings
2025-12-08 English
Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects DoubleDigit Growth in Rrvenues and profitability in 2026
Report Publication Announcement
2025-12-08 English
Annual General Meeting of Shareholders, to be held on Wednesday, December 10, 2025, at 4:00 p.m, Notice and Proxy Statement
Proxy Solicitation & Information Statement
2025-12-02 English
Annual General Meeting of Shareholders, to be held on Wednesday, December 10, 2025, at 4:00 p.m, Notice and Proxy Statement
AGM Information
2025-12-02 English
Kamada Reports Third Quarter and Nine Month 2025 Financial Results
Earnings Release 9M 2025
2025-11-10 English
Kamada Reports Third Quarter and Nine Month 2025 Financial Results
Report Publication Announcement 9M 2025
2025-11-10 English
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation
Regulatory Filings
2025-11-04 English
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation
Report Publication Announcement
2025-11-04 English
Will release financial results for the third quarter 2025, on November 10, 2025, and will host conference call 8:30am ET
Report Publication Announcement
2025-11-03 English
Will release financial results for the third quarter 2025, on November 10, 2025, and will host conference call 8:30am ET
Report Publication Announcement
2025-11-03 English
Kamada to Present at the Stifel 2025 Healthcare Conference
Report Publication Announcement
2025-10-29 English
Kamada to Present at the Stifel 2025 Healthcare Conference
Regulatory Filings
2025-10-29 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2025, PROXY STATEMENT
Proxy Solicitation & Information Statement
2025-10-23 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2025, PROXY STATEMENT
Proxy Solicitation & Information Statement
2025-10-23 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2025, PROXY STATEMENT
AGM Information
2025-10-23 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2025, PROXY STATEMENT
Proxy Solicitation & Information Statement
2025-10-23 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 10, 2025, PROXY STATEMENT
Report Publication Announcement
2025-10-23 English
Kamada to Participate in Upcoming September Investor Conferences
Regulatory Filings
2025-09-02 English
Kamada to Participate in Upcoming September Investor Conferences
Regulatory Filings
2025-09-02 English
Second Quarter and First Half 2025 Financial Results
Earnings Release Q2 2025
2025-08-13 English
Second Quarter and First Half 2025 Financial Results
Earnings Release H1 2025
2025-08-13 English
FDA Approval of its Plasma Collection Center in Houston, Texas
Regulatory Filings
2025-08-11 English
FDA Approval of its Plasma Collection Center in Houston, Texas
Regulatory Filings
2025-08-11 English
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Results and Host Conference Call on August 13,2025
Earnings Release H1 2025
2025-08-06 English
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Results and Host Conference Call on August 13,2025
Report Publication Announcement
2025-08-06 English
Due to an error, trade halt was initiated in KAMADA's shares instead of CAMTEK's shares, trade in KAMADA's shares was renewed at 14:32.
Regulatory Filings
2025-08-05 English
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East מאשרת פעילות עסקיתגלובלית מ
Regulatory Filings
2025-06-17 English
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East מאשרת פעילות עסקיתגלובלית מ
Regulatory Filings
2025-06-17 English
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability
Earnings Release Q1 2025
2025-05-14 English
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability
Report Publication Announcement
2025-05-14 English
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
Earnings Release Q1 2025
2025-05-07 English
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
Report Publication Announcement
2025-05-07 English
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM
Regulatory Filings
2025-05-05 English
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM
Report Publication Announcement
2025-05-05 English
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
Regulatory Filings
2025-03-24 English
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
Regulatory Filings
2025-03-24 English
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
Regulatory Filings
2025-03-19 English
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
Report Publication Announcement
2025-03-19 English
20F Annual filing 2024
Annual Report FY 2024
2025-03-05 English
20F Annual filing 2024
Report Publication Announcement FY 2024
2025-03-05 English
financial results for the three months and year ended December 31, 2024
Earnings Release FY 2024
2025-03-05 English
financial results for the three months and year ended December 31, 2024
Report Publication Announcement
2025-03-05 English
Fourth Quarter and Fiscal Year 2024 Financial Results and conference call on March 5, 2025
Report Publication Announcement
2025-02-26 English
Fourth Quarter and Fiscal Year 2024 Financial Results and conference call on March 5, 2025
Report Publication Announcement
2025-02-26 English
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
Regulatory Filings
2025-01-22 English
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
Report Publication Announcement
2025-01-22 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Regulatory Filings
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Regulatory Filings
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
AGM Information
2025-01-08 English
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Report Publication Announcement
2025-01-08 English